Tags

Type your tag names separated by a space and hit enter

A new coronavirus associated with human respiratory disease in China.
Nature. 2020 03; 579(7798):265-269.Nat

Abstract

Emerging infectious diseases, such as severe acute respiratory syndrome (SARS) and Zika virus disease, present a major threat to public health1-3. Despite intense research efforts, how, when and where new diseases appear are still a source of considerable uncertainty. A severe respiratory disease was recently reported in Wuhan, Hubei province, China. As of 25 January 2020, at least 1,975 cases had been reported since the first patient was hospitalized on 12 December 2019. Epidemiological investigations have suggested that the outbreak was associated with a seafood market in Wuhan. Here we study a single patient who was a worker at the market and who was admitted to the Central Hospital of Wuhan on 26 December 2019 while experiencing a severe respiratory syndrome that included fever, dizziness and a cough. Metagenomic RNA sequencing4 of a sample of bronchoalveolar lavage fluid from the patient identified a new RNA virus strain from the family Coronaviridae, which is designated here 'WH-Human 1' coronavirus (and has also been referred to as '2019-nCoV'). Phylogenetic analysis of the complete viral genome (29,903 nucleotides) revealed that the virus was most closely related (89.1% nucleotide similarity) to a group of SARS-like coronaviruses (genus Betacoronavirus, subgenus Sarbecovirus) that had previously been found in bats in China5. This outbreak highlights the ongoing ability of viral spill-over from animals to cause severe disease in humans.

Authors+Show Affiliations

Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.Department of Pulmonary and Critical Care Medicine, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.Wuhan Center for Disease Control and Prevention, Wuhan, China.Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.Department of Zoonosis, National Institute for Communicable Disease Control and Prevention, China Center for Disease Control and Prevention, Beijing, China.Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.Department of Pulmonary and Critical Care Medicine, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.Department of Pulmonary and Critical Care Medicine, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.Wuhan Center for Disease Control and Prevention, Wuhan, China.Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.Department of Pulmonary and Critical Care Medicine, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.Shanghai Public Health Clinical Center, Fudan University, Shanghai, China. Marie Bashir Institute for Infectious Diseases and Biosecurity, School of Life and Environmental Sciences and School of Medical Sciences, The University of Sydney, Sydney, New South Wales, Australia.Shanghai Public Health Clinical Center, Fudan University, Shanghai, China. zhangyongzhen@shphc.org.cn. Department of Zoonosis, National Institute for Communicable Disease Control and Prevention, China Center for Disease Control and Prevention, Beijing, China. zhangyongzhen@shphc.org.cn. School of Public Health, Fudan University, Shanghai, China. zhangyongzhen@shphc.org.cn.

Pub Type(s)

Case Reports
Journal Article

Language

eng

PubMed ID

32015508

Citation

Wu, Fan, et al. "A New Coronavirus Associated With Human Respiratory Disease in China." Nature, vol. 579, no. 7798, 2020, pp. 265-269.
Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265-269.
Wu, F., Zhao, S., Yu, B., Chen, Y. M., Wang, W., Song, Z. G., Hu, Y., Tao, Z. W., Tian, J. H., Pei, Y. Y., Yuan, M. L., Zhang, Y. L., Dai, F. H., Liu, Y., Wang, Q. M., Zheng, J. J., Xu, L., Holmes, E. C., & Zhang, Y. Z. (2020). A new coronavirus associated with human respiratory disease in China. Nature, 579(7798), 265-269. https://doi.org/10.1038/s41586-020-2008-3
Wu F, et al. A New Coronavirus Associated With Human Respiratory Disease in China. Nature. 2020;579(7798):265-269. PubMed PMID: 32015508.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - A new coronavirus associated with human respiratory disease in China. AU - Wu,Fan, AU - Zhao,Su, AU - Yu,Bin, AU - Chen,Yan-Mei, AU - Wang,Wen, AU - Song,Zhi-Gang, AU - Hu,Yi, AU - Tao,Zhao-Wu, AU - Tian,Jun-Hua, AU - Pei,Yuan-Yuan, AU - Yuan,Ming-Li, AU - Zhang,Yu-Ling, AU - Dai,Fa-Hui, AU - Liu,Yi, AU - Wang,Qi-Min, AU - Zheng,Jiao-Jiao, AU - Xu,Lin, AU - Holmes,Edward C, AU - Zhang,Yong-Zhen, Y1 - 2020/02/03/ PY - 2020/01/07/received PY - 2020/01/28/accepted PY - 2020/2/6/pubmed PY - 2020/3/21/medline PY - 2020/2/5/entrez SP - 265 EP - 269 JF - Nature JO - Nature VL - 579 IS - 7798 N2 - Emerging infectious diseases, such as severe acute respiratory syndrome (SARS) and Zika virus disease, present a major threat to public health1-3. Despite intense research efforts, how, when and where new diseases appear are still a source of considerable uncertainty. A severe respiratory disease was recently reported in Wuhan, Hubei province, China. As of 25 January 2020, at least 1,975 cases had been reported since the first patient was hospitalized on 12 December 2019. Epidemiological investigations have suggested that the outbreak was associated with a seafood market in Wuhan. Here we study a single patient who was a worker at the market and who was admitted to the Central Hospital of Wuhan on 26 December 2019 while experiencing a severe respiratory syndrome that included fever, dizziness and a cough. Metagenomic RNA sequencing4 of a sample of bronchoalveolar lavage fluid from the patient identified a new RNA virus strain from the family Coronaviridae, which is designated here 'WH-Human 1' coronavirus (and has also been referred to as '2019-nCoV'). Phylogenetic analysis of the complete viral genome (29,903 nucleotides) revealed that the virus was most closely related (89.1% nucleotide similarity) to a group of SARS-like coronaviruses (genus Betacoronavirus, subgenus Sarbecovirus) that had previously been found in bats in China5. This outbreak highlights the ongoing ability of viral spill-over from animals to cause severe disease in humans. SN - 1476-4687 UR - https://www.unboundmedicine.com/medline/citation/32015508/A_new_coronavirus_associated_with_human_respiratory_disease_in_China_ DB - PRIME DP - Unbound Medicine ER -